Supplementary Tables S1-S11 from Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic <i>TP53</i>-Mutant Clonal Hematopoiesis

Supplementary Tables S1-S11 from Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic <i>TP53</i>-Mutant Clonal Hematopoiesis

<p>Supplementary Table 1. Karyotypes of LH-ALL patients at diagnosis. Supplementary Table 2. Somatic variants detected in LH-ALL patients at diagnosis. Supplementary Table 3. ARCH related variants detected in LH-ALL patients at remission. Supplementary Table 4. Minimal residual disease values...

Szczegółowa specyfikacja

Zapisane w:

Opis bibliograficzny
1. autor:	Rathana Kim (15135915) (author)
Kolejni autorzy:	Hugo Bergugnat (15135918) (author), Lise Larcher (15135921) (author), Matthieu Duchmann (15049433) (author), Marie Passet (15135924) (author), Stéphanie Gachet (15118876) (author), Wendy Cuccuini (15135927) (author), Marina Lafage-Pochitaloff (15135930) (author), Cédric Pastoret (15135933) (author), Nathalie Grardel (15135936) (author), Vahid Asnafi (15135939) (author), Beat W. Schäfer (15135942) (author), Eric Delabesse (15047352) (author), Raphaël Itzykson (15135945) (author), Lionel Adès (15049442) (author), Yosr Hicheri (15135948) (author), Yves Chalandon (15018422) (author), Carlos Graux (15135951) (author), Patrice Chevallier (15135954) (author), Mathilde Hunault (15135957) (author), Thibaut Leguay (15135960) (author), Françoise Huguet (15047328) (author), Véronique Lhéritier (15135963) (author), Hervé Dombret (15049448) (author), Jean Soulier (15135966) (author), Philippe Rousselot (15135969) (author), Nicolas Boissel (15135972) (author), Emmanuelle Clappier (15118873) (author)
Wydane:	2025
Hasła przedmiotowe:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Genome Biology Hematological Cancers Leukemias Single Cell Technologies Translational Research
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy

Suppl Data 2 from Whole Slide Imaging-Based Prediction of <i>TP53</i> Mutations Identifies an Aggressive Disease Phenotype in Prostate Cancer
od: Marija Pizurica (17060224)
Wydane: (2025)

Suppl. Data 1 from Whole Slide Imaging-Based Prediction of <i>TP53</i> Mutations Identifies an Aggressive Disease Phenotype in Prostate Cancer
od: Marija Pizurica (17060224)
Wydane: (2025)

Supplemental Table S3 from Clonal Hematopoiesis in Young Women Treated for Breast Cancer
od: Christopher J. Gibson (15907642)
Wydane: (2025)

Supplemental Table S4 from Clonal Hematopoiesis in Young Women Treated for Breast Cancer
od: Christopher J. Gibson (15907642)
Wydane: (2025)

Table S1-S3 from Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors
od: Wei Hong (432102)
Wydane: (2025)

Supplementary Figure 1 from Polymorphisms in <i>Cyclooxygenase</i>, <i>Lipoxygenase</i>, and <i>TP53</i> Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial
od: John R. Davies (17314989)
Wydane: (2025)

Supplementary Figure 2 from Polymorphisms in <i>Cyclooxygenase</i>, <i>Lipoxygenase</i>, and <i>TP53</i> Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial
od: John R. Davies (17314989)
Wydane: (2025)

Supplementary Figure 3 from Polymorphisms in <i>Cyclooxygenase</i>, <i>Lipoxygenase</i>, and <i>TP53</i> Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial
od: John R. Davies (17314989)
Wydane: (2025)

Supplementary Table 2 from Polymorphisms in <i>Cyclooxygenase</i>, <i>Lipoxygenase</i>, and <i>TP53</i> Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial
od: John R. Davies (17314989)
Wydane: (2025)

Supplementary Figure S11 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
od: Leon J. Wils (15055780)
Wydane: (2025)

Table 1 from Addressing Common Misuses and Pitfalls of <i>P</i> values in Biomedical Research
od: Ming Wang (8809334)
Wydane: (2025)

Supplementary Figure 1 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
od: Anne-Florence Blandin (15056366)
Wydane: (2025)

Supplementary Figure 2 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
od: Anne-Florence Blandin (15056366)
Wydane: (2025)

Supplementary Figure 3 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
od: Anne-Florence Blandin (15056366)
Wydane: (2025)

Supplementary Figure 4 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
od: Anne-Florence Blandin (15056366)
Wydane: (2025)

Supplementary Figure 5 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
od: Anne-Florence Blandin (15056366)
Wydane: (2025)

Supplementary Figure 6 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
od: Anne-Florence Blandin (15056366)
Wydane: (2025)

Supplementary Tables S1-S10 from <i>ACTA2</i> Expression Predicts Survival and Is Associated with Response to Immune Checkpoint Inhibitors in Gastric Cancer
od: Sunho Park (15053897)
Wydane: (2025)

Supplementary Tables 1-8 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
od: Anne-Florence Blandin (15056366)
Wydane: (2025)

Supplementary Tables from Biallelic <i>Dicer1</i> Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of <i>DICER1</i> Syndrome–Associated Cancer
od: Yemin Wang (17315078)
Wydane: (2025)

Figure 1 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma
od: Nicholas T. Younger (14956251)
Wydane: (2025)

Figure 2 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma
od: Nicholas T. Younger (14956251)
Wydane: (2025)

Figure 3 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma
od: Nicholas T. Younger (14956251)
Wydane: (2025)

Figure 4 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma
od: Nicholas T. Younger (14956251)
Wydane: (2025)

Supplemental Tables 1-8 from Colorectal Cancer Metastases in the Liver Establish Immunosuppressive Spatial Networking between Tumor-Associated <i>SPP1</i><sup>+</sup> Macrophages and Fibroblasts
od: Anuja Sathe (15028097)
Wydane: (2025)

Supplementary Table S3 from Loss of <i>CDKN2A</i> Cooperates with <i>WWTR1(TAZ)–CAMTA1</i> Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma
od: Caleb N. Seavey (15056489)
Wydane: (2025)

Supplementary Table S4 from Loss of <i>CDKN2A</i> Cooperates with <i>WWTR1(TAZ)–CAMTA1</i> Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma
od: Caleb N. Seavey (15056489)
Wydane: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
od: Feng Wang (44414)
Wydane: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
od: Feng Wang (44414)
Wydane: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
od: Feng Wang (44414)
Wydane: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
od: Feng Wang (44414)
Wydane: (2025)

Figure S1 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
od: Subhamoy Chakraborty (16648124)
Wydane: (2025)

Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
od: Subhamoy Chakraborty (16648124)
Wydane: (2025)

Figure S3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
od: Subhamoy Chakraborty (16648124)
Wydane: (2025)

Supplementary Data 1 from Unique Spectrum of Activating <i>BRAF</i> Alterations in Prostate Cancer
od: Alex Chehrazi-Raffle (17079582)
Wydane: (2025)

Supplementary Figure 1 from Unique Spectrum of Activating <i>BRAF</i> Alterations in Prostate Cancer
od: Alex Chehrazi-Raffle (17079582)
Wydane: (2025)

Supplementary Tables from <i>In Vivo</i> Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities
od: Elisa ten Hacken (15136187)
Wydane: (2025)

Supplementary Tables 1-3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
od: Subhamoy Chakraborty (16648124)
Wydane: (2025)

Supplementary Data 1 from Early Changes in Circulating Cell-Free <i>KRAS</i> G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients
od: Cloud P. Paweletz (14960112)
Wydane: (2025)

Climate-driven emergence of nitrogen export hotspots in northern China's croplands
od: jie Qiu (19440868)
Wydane: (2025)

Cannot write session to /tmp/vufind_sessions/sess_irc9i1m9i31qsquuvmhhjpk1d5